SPY328.79+2.27 0.70%
DIA266.72+2.37 0.90%
IXIC10,902.80+157.52 1.47%
News
PDSB
--
0.00%
--
PDS Biotechnology Announces Conference Call and Webcast for Second Quarter 2020 Financial Results
FLORHAM PARK, N.J., July 30, 2020 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company’s proprietary Versamune® T-cell ac
GlobeNewswire · 4d ago
PDS Biotech COVID-19 vaccine candidate shows encouraging preclinical action
Seeking Alpha · 07/27 13:47
PDS Biotech Announces Preclinical Data for PDS0203, a T-Cell Activating Recombinant Protein Vaccine Against COVID-19
Versamune-CoV-2 (PDS0203) generated high levels of robust, long-lasting CD8 (killer) T-cell responses and potent neutralizing antibody responses within 14 days of vaccinationFLORHAM PARK, N.J., July 27, 2020 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (N
GlobeNewswire · 07/27 12:30
NAK, EXK among premarket gainers
Seeking Alpha - Article · 07/22 12:16
OPK, NBEV, DVAX and ACAD among midday movers
Seeking Alpha - Article · 07/21 16:39
NKLA, IBIO, PETS and TNXP among midday movers
Seeking Alpha - Article · 07/20 16:39
80 Biggest Movers From Friday
Gainers Berkeley Lights, Inc. (NASDAQ: BLI) shares jumped 197.5% to close at $65.45 on Friday after the company priced its 8.1 million share IPO at $22 per share.
Benzinga · 07/20 09:11
PDS Biotech collaborator nabs NIAID award for development of influenza vaccine
PDS Biotechnology (NASDAQ:PDSB) collaborator, Professor J. Woodward of the University of Kentucky School of Medicine, has been awarded a grant from the Nat
seekingalpha · 07/14 18:04
PDS Biotech Collaborator Granted NIAID Award To Accelerate Development Of Versamune-Based Universal Influenza Vaccine
Benzinga · 07/14 12:38
PDS Biotech Collaborator Granted NIAID Award to Accelerate Development of Versamune®-Based Universal Influenza Vaccine
PDS Biotech ramps up third infectious disease vaccine program, PDS0202 for influenza, following PDS0201 for tuberculosis and PDS0203 for COVID-19FLORHAM PARK, N.J., July 14, 2020 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stag
GlobeNewswire · 07/14 12:30
BIIB, MFGP among premarket gainers
Seeking Alpha - Article · 07/08 12:17
GNW, WKHS, ZYNE and BE among midday movers
Seeking Alpha - Article · 06/30 16:41
GNW, IIPR among premarket losers
Seeking Alpha - Article · 06/30 12:15
ICPT, WKHS, HRTX and BLNK among midday movers
Seeking Alpha - Article · 06/29 16:41
NKLA, COTY among premarket gainers
Seeking Alpha - Article · 06/29 12:24
GPS, LK, IBIO and MMLP among midday movers
Seeking Alpha - Article · 06/26 16:42
PDS Biotechnology Shares Move Higher; Hearing Co. To Present Key Data For Developing SARS-CoV-2 Program Based On Versamune Platform
-Chardan
Chardan · 06/26 16:20
PDS Biotech Announces Publication of Preclinical Results Of PDS0101 Combination By The National Cancer Institute In The Journal For ImmunoTherapy Of Cancer
PDS Biotech Announces Publication of Preclinical Results of PDS0101 Combination by the National Cancer Institute in the Journal for ImmunoTherapy of Cancer FLORHAM PARK, N.J., June 22, 2020 (GLOBE NEWSWIRE) -- PDS
Benzinga · 06/22 12:34
PDS Biotech Announces Publication of Preclinical Results of PDS0101 Combination by the National Cancer Institute in the Journal for ImmunoTherapy of Cancer
PDS Biotechnology Corporation (PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company’s proprietary Versamune® T-cell activating technology, today announced the publication of data g
GlobeNewswire · 06/22 12:30
PDS Biotechnology and Farmacore Biotechnology Announce Co-Development of PDS0204 COVID-19 Vaccine
GlobeNewswire · 06/17 13:30